Discover how the experimental drug lepodisiran dramatically lowers lipoprotein(a) levels, potentially transforming treatment ...

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be ...

An intensive three-drug regimen of heart medications did not significantly impact the rate of serious cardiovascular events ...

Patients with aortic stenosis were excluded from earlier trials of the SGLT2 inhibitor, but new data confirm they too can ...

A new study that looked at how liberal vs. restrictive fluid restriction impacts health status for patients with chronic ...

Despite showing no overall benefit, the in-home paramedic visit appeared to help women avoid readmissions more than men.

No serious adverse events related to the drug were reported. "What we have is a drug that can lower lipoprotein(a) with very ...

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...

Advances in PCI over the past decade mean the procedure can now approximate results only previously achieved with open-heart bypass surgery, new data show.

Turmeric coffee is made by adding turmeric and other spices to coffee. The beverage may help reduce inflammation and support ...